论文部分内容阅读
发炎已被证实为哮喘的一个重要机理。哮喘患者由于气道反应性高,受过敏因素激发和作用,无论哮喘发作与否,支气管炎症始终存在。根据这一认识,以炎症为重点的哮喘治疗显得更加合理。 哮喘的治疗可分三类:(1)缓解症状治疗;(2)预防性治疗;(3)急性发作的治疗。 第一类治疗的药物有β-受体兴奋剂,抗胆碱能作用剂及茶硷三类支气管舒张剂。常用的β-受体兴奋剂有舒喘灵、叔丁喘宁、酚丙喘宁,这些药物
Inflammation has been shown to be an important mechanism of asthma. Asthma patients have high levels of airway reactivity and are stimulated and affected by allergic factors, and bronchial inflammation always exists regardless of the onset of asthma. Based on this understanding, inflammation-focused asthma treatment is more reasonable. The treatment of asthma can be divided into three categories: (1) to alleviate the symptoms of treatment; (2) prophylactic treatment; (3) the treatment of acute attacks. The first class of drugs for treatment are β-receptor agonists, anticholinergic agents and theophylline bronchodilators. Common beta-receptor agonists are salbutamol, terbutaline, phenprodin, these drugs